The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence

Completed · Phase 3 · Has a placebo group

Conditions studied: Urinary Incontinence, Stress

In brief

Over 11 million women in the United States suffer from stress urinary incontinence (SUI), the involuntary leakage of urine during routine physical activities such as laughing, coughing, exercising, or sneezing. SUI affects women of all ages and can result in significant emotional distress. The purpose of this study is to evaluate a non-surgical, investigational treatment intended to reduce or eliminate urine leakage due to stress urinary incontinence.

Key facts

Study ID
NCT00492596
Run by
Solace Therapeutics, Inc.
People needed
166
Starts
2006-06-01
Expected to finish
2011-06-01
Last updated by the study team
2014-08-11

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.